NEW YORK, Oct. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Veterinary Vaccines Industry
http://www.reportlinker.com/p092485/Global-Veterinary-Vaccines-Industry.html
This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million by the following Product segments: Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets. The report profiles 60 companies including many key and niche players such as Bayer HealthCare AG, Biogenesis-Bago, Fort Dodge Animal Health, Heska Corporation, Imugene Limited, Indian Immunologicals Ltd., Lohmann Animal Health, Merck & Co., Inc., Intervet/Schering-Plough Animal Health, Merial Ltd., Pfizer, Inc., Embrex, Inc., Protein Sciences Corporation, and Virbac Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
VETERINARY VACCINES MCP-1129
A GLOBAL STRATEGIC BUSINESS REPORT
CONTENTS
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 3
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
A.Companion Animal Vaccines 4
B.Livestock Vaccines 4
Porcine Vaccines 4
Bovine Vaccines 4
Poultry Vaccines 4
Ovine Vaccines 4
Equine Vaccines 5
Other Animal Vaccines 5
2. INDUSTRY OVERVIEW & OUTLOOK 6
Global Animal Health Care Industry - A Brief Review 6
Table 1: Global Animal Health Products Market by Region
(2008): Percentage Share Breakdown by Value Sales for North
America, Europe, Latin America and Rest of World (includes
corresponding Graph/Chart) 6
Table 2: Global Animal Health Products Market by Product
Group (2008): Percentage Share Breakdown by Value sales for
Parasiticides, Vaccines, Anti-Infectives, Medical Feed
Additives and Other Pharmaceuticals (includes corresponding
Graph/Chart) 6
Animal Healthcare Market Grows Amidst Recession 7
Veterinary Vaccines Industry Posts Moderate Growth 7
Poultry Vaccines Industry: A Global Scenario 7
Improved Manufacturing Techniques 8
Improved Analysis 8
Scope of the Report 8
Current and Future Analysis 8
Analysis by Product Segment 9
Companion Animal Vaccines 9
Livestock Vaccines 9
Analysis by Region 9
Companion Animal Vaccines Market 9
Livestock Vaccines Market 9
3. MARKET TRENDS & ISSUES 10
Companion Animal Vaccines: Trailing on a High Growth Track 10
OTC Market: A Potential Threat for Veterinarians 10
Small Animal Practitioners Feel the Pinch of Recession 10
Parasiticides, Systemic Agents To Drive The Market 10
Taxonomy of Vaccines 10
Bird Flu - The Aftermath 11
Vaccination - Critical for Controlling Avian Influenza Virus 11
4. PRODUCT OVERVIEW 12
Vaccines - An Evolutionary Scan 12
Contribution of Animal Research to Vaccine Production 12
Veterinary Medicines- A Brief Review 13
Preventive Medicines 13
Therapeutic Medicines 13
Others 13
Development of Vaccines 13
Production of Vaccines 14
Veterinary Vaccines - An Essential Component of Animal Health
Care 14
What Does A Veterinary Vaccine Do? 15
Classification of Veterinary Vaccines 15
Companion Animals Vaccines 15
Canine Vaccines 15
Feline Vaccines 17
Livestock Vaccines 18
Bovine Vaccines 18
Poultry Vaccines 19
Ovine Vaccines 19
Porcine Vaccines 20
Equine Vaccines 20
Aquaculture Vaccines 20
A Tabular Analysis on Select Animal Diseases Controlled by
Vaccines 21
Vaccination and Its Reactions 21
Veterinary Vaccines- Latest Breakthroughs 21
Marker vaccines 21
DNA vaccines 21
Gene-deleted vaccines 22
Viral-vectored vaccines 22
5. NOTES ON SELECT ANIMAL DISEASES 23
Brucellosis 23
Tuberculosis 23
Johne's disease 23
Spirochete Associated Diseases 23
Respiratory Disease in Goats, Sheep, and Cattle 24
Porcine Respiratory Diseases 24
Mastitis 24
African Swine Fever 24
Avian Influenza 25
East Coast Fever 25
Hemorrhagic Septicemia 25
Foot-And-Mouth Disease 25
Japanese Encephalitis 25
Rift Valley Fever 26
Equine Virus 26
6. PRODUCT INNOVATIONS/INTRODUCTIONS 27
Intervet Schering Plough Animal Health Introduces Circovirosis
Vaccine 27
Pfizer Animal Health Develops Inovocox® Vaccine 27
Intervet/Schering-Plough Animal Health Launches Bravoxin 10 27
Bioject and Merial Rolls Out Derma-Vac NF 27
Defra to Launch Bovine Tuberculosis Vaccine 28
Intervet International Develops Bluetongue Vaccine 28
Hester Biosciences Unveils Anti-Coryza Vaccine 28
Intervet/Schering-Plough Animal Health Introduces Bovilis BTV8
Vaccine 28
Tecnovax Develops Vaccine for Salmon Virus 29
Tamil Nadu Veterinary and Animal Science University and The
Indian Veterinary Research Institute Develop Vaccine 29
Lohmann Animal Health Develops AviPro IBD Xtreme 29
Intervet/Schering-Plough Animal Health Launches EquiRab™ 29
Lohmann Animal Health Introduces Larger Doses of AviPro®
ViBursa CE 29
Lohmann Animal Health International Rolls Out AviBlue 30
Fort Dodge Animal Health Unveils West Nile-Innovator DNA 30
Univet Agricultural Products Introduces Coglapest 30
Intervet/Schering-Plough Animal Health Launches Porcilis® COLI 6C 31
Pfizer Animal Health Unveils FluSure® XP Defense System 31
Pfizer Animal Health Launches Improvac® 31
Intervet/Schering-Plough Animal Health Develops Onset™ 5
Intranasal (IN) Vaccine 31
Merial Rolls Out BTVPUR AlSap 8 32
Pfizer Animal Health Introduces FarrowSure® GOLD and
FarrowSure® GOLD B 32
Schering-Plough Animal Health Unveils CAVALRY 9 32
Lohmann Animal Health Develops BTO2 REO Vaccine 33
7. PRODUCT INNOVATIONS/INTRODUCTIONS IN RECENT PAST - A
PERSPECTIVE BUILDER 34
Agroinsuvet Introduces New Vaccines 34
Merial Rolls Out Vaxxitek® HVT+IBD Hatchery Vaccine for
Poultry Industry 34
Intervet & Friedrich-Loeffler-Institute Develop Dual Vaccine
Prototype for Birds 34
Schering-Plough Receives USDA License for its Rhusigen™
Erysipelas Vaccine 34
USDA Approves Use of PreveNile™ Vaccine for Horses 35
Fort Dodge Animal Health Develops Reverse Genetics Avian Vaccine 35
Boehringer Ingelheim's Swine Vaccine Gains Approval in Australia 35
Merial Limited Gets USDA Approval for DNA Vaccine for Melanoma
in Dogs 35
Embrex's Poultry Vaccine Inovocox Gets USDA Approval 36
Skystar Bio-Pharmaceutical Develops Avian Influenza Vaccine 36
United States Department of Agriculture Grants Conditional
License for Necrotic Enteritis Vaccine 36
Fort Dodge Receives USDA License for Pyramid®10 37
USDA Licenses Use of Fort Dodge's Suvaxyn® PCV2 Vaccine in Pigs 37
USDA Grants Conditional License to Pfizer's New Canine Vaccine 37
8. RECENT INDUSTRY ACTIVITY 38
Virbac Acquires 30% Share in Santa Elena 38
Merck and Sanofi-Aventis to Merge their Animal Health Business 38
Elanco to Take Over Pfizer's Animal Health Products Portfolio 38
Boehringer Ingelheim to Acquire Pfizer's Fort Dodge Animal
Health Unit 38
ImmunoVaccine Inks Deal with Pfizer 39
Merck Merges with Schering-Plough 39
Pfizer Acquires Wyeth 39
Merial Receives Marketing License for BTVPUR AlSap 8 Vaccine 40
Epitopix Obtains Approval to Sell Siderophore Receptor and
Porin Vaccine 40
Phibro Animal Health Acquires Animal Health Division of Abic 40
Fort Dodge Animal Health and Vivalis Sign Commercial License Deal 41
Hester Biosciences Expands Gujarat Based Facility 41
Intervet/Schering-Plough Animal Health Replaces Bovilis® IBR
Vaccine with Bovilis® IBR Marker Live 41
Tangshan Yian Biological Engineering Wins Approval from
Ministry of Agriculture of China 41
Lohmann Animal Health International Signs an Agreement with
Celldex Therapeutics 42
Intervet/Schering-Plough Animal Health Starts New
Manufacturing Facility 42
Laprovet Commences New Facility 42
ImmunoVaccine Technologies and La Jolla Institute for Allergy &
Immunology Enter into an Agreement 42
Merial Signs a Toll Distribution and Manufacturing Agreement
with Newport Laboratories 43
BOEHRINGER INGELHEIM Animal Health Signs Research License Deal
with Vivalis 43
AviTech Selects Merial as a Distributor and Service Provider 43
Bayer Inks Agreement with Juvaris 44
Pfizer Inks Agreement with ImmunoVaccine Technologies 44
BioVet Inaugurates BSL-4 Production Unit in India 44
Vaxine to Take over Protein Sciences 44
Pfizer Inaugurates a New Development Facility for Veterinary
Vaccines 44
Merial to Establish Animal Vaccine Manufacturing Plant 44
BNC Bioniche Life Sciences Bags Approval to Sell Econiche
Vaccines 45
Hind Bio-Pharmaceuticals to Establish Animal Vaccines Division 45
Pfizer's Animal Health Unit Acquires Schering-Plough's Product
License in Europe 45
Grupo Mathiesen Takes Over Centro de Diagnostico Veterinario 45
Harbin Veterinary Research Institute Opens Animal Vaccine
Manufacturing Base 46
Bioject Medical Technologies Enters into a Long-Term Supply,
Development and License Contract with Merial 46
Vivalis SA Signs Letter of Intent with Intervet/ Schering-Plough 46
Biochemiq Enters into Partnership with Labovet 46
Microbix Biosystems Purchases Production Plant 47
Beijing Veterinary Biological Product Factory Starts Operation
in New Plant 47
Changzhou Tongtai Biopharmaceutical Sets Up Rabies Vaccine
Facility 47
Schering-Plough to Sell Health Products of Animals to Pfizer
and Virbac 47
Pfizer Group Establishes a Veterinary Vaccines Development Center 47
Phylaxia to Acquire Gazdasagi Radio and Kozep-europai
Gazterminal Zrt 48
Bayer HealthCare AG's Animal Health Unit Enters into Licensing
Agreement with Juvaris BioTherapeutics 48
Vivalis Enters into a Commercial License Contract with Virbac 48
ImmunoVaccine Technologies Signs Licensing Agreement with
Pfizer Animal Health 48
Kaketsuken and Vivalis Extends Research Collaboration 48
Heska Amends Distribution Contract with Agri Laboratories 49
Prevtec Microbia and Saskatchewan Research Council Receives
Approval to Market and Manufacture Coliprotec 49
Imugene and Merial Enter into an Agreement 49
Celldex Therapeutics Merges with AVANT Immunotherapeutics'
Subsidiary 49
Ceva Sante Animale Acquires Delvet 50
Inovio Biomedical Signs Merger Agreement with VGX Pharmaceuticals 50
Environmental Risk Management Authority Approves equine
Influenza Vaccine 50
Functional Technologies Commences Operations of Phyterra Bio 50
Summit VetPharm Enters into Distribution Partnership with
Webster Veterinary Unit 51
PerOs Receives Establishment and Bacterin License from USDA 51
Wyeth's Fort Dodge Animal Health Unit Acquires Poultry Vaccines 51
Boehringer Ingelheim Vetmedica Receives Approval for Express®
FP and Express® Vaccines from the USDA 52
9. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 53
Merial Bags Major Australian Contract 53
United States Department of Agriculture Approves Intervet Vaccine 53
Merial Pockets Ancare 53
Heska Revises Distribution Agreement with AgriLabs 53
Animal Health International Acquires Kane Veterinary Supplies 54
Industrial Equity Investments Pockets Arysta LifeScience 54
Henry Schein Acquires W&J Dunlop 54
Tecnovax Establishes New Facility 54
Pingtung Agricultural to Set Up an Exclusive Veterinary Park 54
Ouro Fino To Expand Veterinary Product Suite 54
Alpharma Acquires Yantai Jinhai 54
Pfizer Animal Health Acquires Embrex 55
Schering-Plough Acquires Intervet 55
Schering-Plough Acquires Organon BioSciences 55
Intervet Sets Up New Animal Vaccine Production Facility in
Boxmeer 55
Crucell Licenses PER.C6® Technology to Pfizer Animal Health 56
Central Veterinary Research Laboratory to Synthesize New
Animal Vaccines 56
Pfizer to Shut Down Omaha Animal Vaccine Center 56
IGI Licenses Novasomes to Novavax 57
Bogor Agricultural Institute Collaborates with Shigeta Animal
Pharmaceuticals 57
Suguna Poultry Steps into Livestock Vaccine Production Business 57
European Medicines Agency Grants Community Authorization for
Nobilis Influenza H7N1 57
AVANT Immunotherapeutics & Pfizer Collaborate to Develop
Animal Vaccines 58
Intervet International Acquires FMD Vaccine Production
Facility from Bayer Healthcare 58
Canadian Food Inspection Agency Authorizes Bioniche E. Coli
O157:H7 Cattle Vaccine for Field Use 58
Hemispherx Biopharma Acquires DOGS Molecule Patent 59
Hind Industries to Establish Animal Vaccine Formulations Plant
at Patiala 59
Cryosite and Animal Health Australia Form Partnership 59
Hester Pharmaceuticals Plans Capacity Expansion 59
Biovet to Set up Animal Vaccine Plant in Karnataka 59
Bogor Institute of Agricultureand Shigeta Establish JV for
Production of CLOSE 5.1 Vaccine 59
IPB Shigeta Acquires Bird Flu Vaccine Rights from MedImmune 60
Bioject Medical Technologies Signs Three Agreements WithMerial 60
PetCARE Television Network signs Distribution Agreement with
Butler Animal Health Supply 60
Poultry Vaccine to be produced in Vladimir 60
10. RESEARCH AND DEVELOPMENT IN RECENT PAST 61
Scientists Develop New Vaccine Against Disease Related to PCV2 61
Auburn University and Vaxin Researchers Develop Avian Flu Vaccine 61
UK Researchers Develop In-Shell Vaccine for Chicks 61
Researchers in Vietnam Decode the H5N1 Virus Gene 62
Pittsburgh Researchers Create Avian Flu Vaccine from H5N1 Virus 62
University of Warwick Develops Protecting Virus Method 62
New Treatment Measure Against Ovine Salmonella & Brucellosis 63
ICAR Develops Indigenous Bird Flu Vaccine 63
St. Jude Develops Flu Virus Vaccine through Reverse Genetics 63
Researchers Develop Vaccine for Swine Disease 63
Researchers Develop Experimental Vaccine Against 1918
Influenza Virus 64
Study Proves Effectiveness of Intradermal Vaccine
Administration in Rabbits 64
CEL-SCI's CEL-1000 Peptide Shows Adjuvant Activity 65
Progress in Vaccine for Canine Cancer 65
11. FOCUS ON SELECT GLOBAL PLAYERS 66
Bayer HealthCare AG (Germany) 66
Biogenesis-Bago (Argentina) 66
Fort Dodge Animal Health (US) 66
Heska Corporation (US) 67
Imugene Limited (Australia) 67
Indian Immunologicals Ltd (India) 67
Lohmann Animal Health (US) 68
Merck & Co., Inc. (US) 68
Intervet/Schering-Plough Animal Health (The Netherlands) 68
Merial Ltd. (US) 69
Pfizer, Inc. (US) 69
Embrex, Inc. (US) 69
Protein Sciences Corporation (US) 70
Virbac Corporation (US) 70
12. GLOBAL MARKET PERSPECTIVE 71
Table 3: World Recent Past, Current & Future Analysis for
Veterinary Vaccines by Geographic Region - US, Europe and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 71
Table 4: World Historic Review Veterinary Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 72
Table 5: World 11-Year Perspective for Veterinary Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2005, 2010 &
2015(includes corresponding Graph/Chart) 73
Table 6: World Recent Past, Current & Future Analysis for
Companion Animal Vaccines by Geographic Region - US, Europe
and Rest of World Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 74
Table 7: World Historic Review for Companion Animal Vaccines
by Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 75
Table 8: World 11-Year Perspective for Companion Animal
Vaccines by Geographic Region - Percentage Breakdown of Dollar
Sales for US, Europe and Rest of World Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart) 76
Table 9: World Recent Past, Current & Future Analysis for
Companion Animal Vaccines by Product Segment- Canine Vaccines &
Feline Vaccines Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 77
Table 10: World Historic Review for Companion Animal Vaccines
by Product Segment- Canine Vaccines & Feline Vaccines Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 78
Table 11: World 11-Year Perspective for Companion Animal
Vaccines by Product Segment - Percentage Breakdown of Dollar
Sales for Canine Vaccines & Feline Vaccines Markets for Years
2005, 2010 & 2015 78
Table 12: World Recent Past, Current & Future Analysis for
Canine Vaccines by Geographic Region - US, Europe and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 79
Table 13: World Historic Review for Canine Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 80
Table 14: World 11-Year Perspective for Canine Vaccines by
Geographic region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 81
Table 15: World Recent Past, Current & Future Analysis for
Feline Vaccines by Geographic Region - US, Europe and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 82
Table 16: World Historic Review for Feline Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 83
Table 17: World 11-Year Perspective for Feline Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2005, 2010 &
2015(includes corresponding Graph/Chart) 84
Table 18: World Recent Past, Current & Future Analysis for
Livestock Vaccines by Geographic Region - US, Europe and Rest
of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 85
Table 19: World Historic Review for Livestock Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 86
Table 20: World 11-Year Perspective for Livestock Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 87
Table 21: World Recent Past, Current & Future Analysis for
Livestock Vaccines by Product Segment - Porcine Vaccines,
Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine
Vaccines and Other Animal Vaccines Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2007 through 2015 (includes corresponding Graph/Chart) 88
Table 22: World Historic Review for Livestock Vaccines by
Product Segment - Porcine Vaccines, Bovine Vaccines, Poultry
Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal
Vaccines Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 89
Table 23: World 11-Year Perspective for Livestock Vaccines by
Product Segment - Percentage Breakdown of Dollar Sales for
Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines, Equine Vaccines & Other Animal Vaccines Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart) 90
Table 24: World Recent Past, Current & Future Analysis for
Porcine Vaccines by Geographic Region - US, Europe and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 91
Table 25: World Historic Review for Porcine Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 92
Table 26: World 11-Year Perspective for Porcine Vaccines by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 93
Table 27: World Recent Past, Current and Future Analysis for
Bovine Vaccines by Geographic Region - US, Europe & Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 94
Table 28: World Historic Review for Bovine Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 95
Table 29: World 11-Year Perspective for Bovine Vaccines by
Geographic region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2005, 2010 &
2015(includes corresponding Graph/Chart) 96
Table 30: World Recent Past, Current & Future Analysis for
Poultry Vaccines by Geographic Region - US, Europe and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 97
Table 31: World Historic Review for Poultry Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 98
Table 32: World 11-Year Perspective for Poultry Vaccines by
Geographic region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 99
Table 33: World Recent Past, Current & Future Analysis for
Ovine Vaccines by Geographic Region - US, Europe and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 100
Table 34: World Historic Review for Ovine Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 101
Table 35: World 11-Year Perspective for Ovine Vaccines by
Geographic region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2005, 2010 &
2015(includes corresponding Graph/Chart) 102
Table 36: World Recent Past, Current & Future Analysis for
Equine Vaccines by Geographic Region - US, Europe and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 103
Table 37: World Historic Review for Equine Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 104
Table 38: World 11-Year Perspective for Equine Vaccines by
Geographic region - Percentage Breakdown of Dollar Sales for
US, Europe and Rest of World Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 105
Table 39: World Recent Past, Current & Future Analysis for
Other Animal Vaccines by Geographic Region - US, Europe and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 106
Table 40: World Historic Review for Other Animal Vaccines by
Geographic Region - US, Europe and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 107
Table 41: World 11-Year Perspective for Other Animal Vaccines
by Geographic region - Percentage Breakdown of Dollar Sales
for US, Europe and Rest of World Markets for Years 2005, 2010
& 2015(includes corresponding Graph/Chart) 108
13. THE UNITED STATES 109
A.Market Analysis 109
Current & Future Analysis 109
H5N1 Virus: A Conundrum for the US Industry 109
Rabies Cases in the US 109
B.Market Analytics 110
Table 42: US Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Group/Segment - Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and
Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other
Animal Vaccines) Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 110
Table 43: US Historic Review for Veterinary Vaccines by
Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines, Equine Vaccines and Other Animal Vaccines) Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 111
Table 44: US 11-Year Perspective for Veterinary Vaccines by
Product Group/Segment - Percentage Breakdown of Dollar Sales
for Companion Animal Vaccines (Canine Vaccines and Feline
Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine
Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines
and Other Animal Vaccines) Markets for 2005, 2010 & 2015
(includes corresponding Graph/Chart) 112
14. EUROPE 113
A.Market Analysis 113
Current & Future Analysis 113
By Region 113
By Product Segment 113
B.Market Analytics 114
Table 45: European Recent Past, Current & Future Analysis
for Veterinary Vaccines by Geographic Region - France,
Germany, Italy, United Kingdom and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 114
Table 46: European Historic Review for Veterinary Vaccines
by Geographic Region - France, Germany, Italy, United
Kingdom and Rest of Europe Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 115
Table 47: European 11-Year Perspective for Veterinary
Vaccines by Geographic Region - Percentage Breakdown of
Dollar Sales for France, Germany, Italy, United Kingdom and
Rest of Europe for Years 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 116
Table 48: European Recent Past, Current & Future for
Veterinary Vaccines by Product Group/Segment - Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and
Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other
Animal Vaccines) Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 117
Table 49: European Historic Review for Veterinary Vaccines
by Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines, Equine Vaccines and Other Animal Vaccines) Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 118
Table 50: European 11-Year Perspective for Veterinary
Vaccines by Product Group/Segment - Percentage Breakdown of
Dollar Sales for Companion Animal Vaccines (Canine Vaccines
and Feline Vaccines) and Livestock Vaccines (Porcine
Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,
Equine Vaccines and Other Animal Vaccines) Markets for Years
2005, 2010 & 2015(includes corresponding Graph/Chart) 119
14a. FRANCE 120
Market Analysis 120
Table 51: French Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Group/Segment - Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and
Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines and Equine Vaccines)
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 121
Table 52: French Historic Review for Veterinary Vaccines by
Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines, and Equine Vaccines) Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 122
Table 53: French 11-Year Perspective for Veterinary Vaccines
by Product Group/Segment - Percentage Breakdown of Dollar
Sales for Companion Animal Vaccines (Canine Vaccines and
Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,
Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine
Vaccines) Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 123
14b. GERMANY 124
Market Analysis 124
Table 54: German Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Group/Segment - Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and
Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines and Equine Vaccines)
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 125
Table 55: German Historic Review for Veterinary Vaccines by
Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines and Equine Vaccines) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 126
Table 56: German 11-Year Perspective for Veterinary Vaccines
by Product Group/ Segment - Percentage Breakdown of Dollar
Sales for Companion Animal Vaccines (Canine Vaccines and
Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,
Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine
Vaccines) Markets for 2005, 2010 & 2015 (includes
corresponding Graph/Chart) 127
14c. ITALY 128
Market Analysis 128
Table 57: Italian Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Group/Segment - Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and
Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other
Animal Vaccines) Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 129
Table 58: Italian Historic Review for Veterinary Vaccines by
Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines, Equine Vaccines and Other Animal Vaccines) Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 130
Table 59: Italian 11-Year Perspective for Veterinary
Vaccines by Product Group/Segment - Percentage Breakdown of
Dollar Sales for Companion Animal Vaccines (Canine Vaccines
and Feline Vaccines) and Livestock Vaccines (Porcine
Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,
Equine Vaccines and Other Animal Vaccines) Markets for 2005,
2010 & 2015 (includes corresponding Graph/Chart) 131
14d. THE UNITED KINGDOM 132
Market Analysis 132
Table 60: UK Recent Past, Current & Future Analysis for
Veterinary Vaccines by Product Group/Segment - Companion
Animal Vaccines (Canine Vaccines and Feline Vaccines) and
Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,
Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other
Animal Vaccines) Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 133
Table 61: UK Historic Review for Veterinary Vaccines by
Product Group/Segment - Companion Animal Vaccines (Canine
Vaccines and Feline Vaccines) and Livestock Vaccines
(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine
Vaccines, Equine Vaccines and Other Animal Vaccines) Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 134
Table 62: UK 11-Year Perspective for Veterinary Vaccines by
Product Group/Segment - Percentage Breakdown of Dollar Sales
for Companion Animal Vaccines (Canine Vaccines and Feline
Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine
Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines
and Other Animal Vaccines) Markets for 2005, 2010 & 2015
(includes corresponding Graph/Chart) 135
14e. REST OF EUROPE 136
A.Market Analysis 136
Current & Future Analysis 136 A Note on Danish Veterinary
Services 136
The 2002 Standards of Danish Medicines recommend test for
antibody inducing fragments in veterinary vaccines 137
Hungary Vaccinates Birds Across Zoos 137
Russia Mass-Produces Vaccines Against Avian Flu 138
B.Market Analytics 138
Table 63: Rest of Europe Recent Past, Current & Future
Analysis for Veterinary Vaccines - by Product Group/ Segment
for Companion Animal Vaccines (Canine Vaccines and Feline
Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine
Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines
and Other Animal Vaccines) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 138
Table 64: Rest of Europe Historic Review for Veterinary
Vaccines by Product Group/Segment - Companion Animal
Vaccines (Canine Vaccines and Feline Vaccines) and Livestock
Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry
Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal
Vaccines) Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 139
Table 65: Rest of Europe 11-Year Perspective for Veterinary
Vaccines by Product/Segment - Percentage Breakdown of Dollar
Sales for Companion Animal Vaccines (Canine Vaccines and
Feline Vaccines) and Livestock Vaccines (Porcine Vaccines,
Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine
Vaccines and Other Animal Vaccines) Markets for 2005, 2010 &
2015 (includes corresponding Graph/Chart) 140
15. REST OF WORLD 141
A.Market Analysis 141
Current & Future Analysis 141
Focus on Select Regions 141
Canada 141
Overview of Canadian Animal Health Industry 141
Import and Manufacture of Veterinary Biologics 141
First to Access E. coli 0157:H7 Vaccine 142
China 142
A Glance at the Animal Vaccine Market in China 142
China Initiates Mass Vaccination Campaign Against Bird Flu
Virus 143
Australia 143
A Note on Australian Veterinary Therapeutics Market 143
India 143
ICAR Develops Indigenous Bird Flu Vaccine 143
Thailand 144
Japan & Thailand to Cooperate for Developing Bird Flu Vaccine 144
Taiwan 144
Taiwan's Animal Healthcare Industry Under Scan 144
Malaysia 144
Malaysia Initiates Measures to Deal with Potential Flu
Pandemic 144
Kazakhstan 145
Kazakhstan Takes Proactive Measures Against Bird Flu 145
North Korea 145
North Korea Develops Bird Flu Vaccine 145
Vietnam 145
Vietnam Imports Bird Flu Vaccines 145
Egypt 145
Egypt Reports H5N1 Infection in Vaccinated Flocks 145
Kenya 146
Kenya Mass-Manufactures Vaccines Against Rift Valley Fever 146
B.Market Analytics 146
Table 66: Rest of World Recent Past, Current & Future
Analysis for Veterinary Vaccines - by Product Group/ Segment
for Companion Animal Vaccines (Canine Vaccines and Feline
Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine
Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines
and Other Animal Vaccines) Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart) 146
Table 67: Rest of World Historic Review for Veterinary
Vaccines by Product Group/Segment - Companion Animal
Vaccines (Canine Vaccines and Feline Vaccines) and Livestock
Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry
Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal
Vaccines) Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 147
Table 68: Rest of World 11-Year Perspective for Veterinary
Vaccines by Product Group/Segment - Percentage Breakdown of
Dollar Sales for Companion Animal Vaccines (Canine Vaccines
and Feline Vaccines) and Livestock Vaccines (Porcine
Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,
Equine Vaccines and Other Animal Vaccines) Markets for 2005,
2010 & 2015 (includes corresponding Graph/Chart) 148
COMPETITIVE LANDSCAPE
Total Companies Profiled: 60 (including Divisions/Subsidiaries - 101)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 31
Canada 2
Japan 3
Europe 33
France 2
Germany 9
The United Kingdom 4
Italy 2
Rest of Europe 16
Asia-Pacific (Excluding Japan) 25
Latin America 1
Africa 1
Middle-East 5
------------------------------------------
To order this report:
Veterinary healthcare Industry: Global Veterinary Vaccines Industry
Veterinary healthcare Business News
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article